在移植中使用伊米利菲达酶
Mehmet Kanbay1, Sidar Copur2, Mustafa Guldan2
1Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
Clinical kidney journal
|March 20, 2024
概括
免疫酶是一种IgG降解酶,对具有正交叉匹配的移植接受者来说是有前途的. 然而,IgG反弹需要强大的免疫抑制,突显了对比研究的需要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 移植对于末期病是最优的,但受到抗体敏感化和正交叉匹配的阻碍.
- 积极的交叉匹配增加了排斥的风险,延迟的移植功能,和全移植损失,尽管目前的无敏化协议.
- 免疫酶是一种IgG降解酶,在临床前和临床研究中为积极的交叉匹配移植提供了快速的疗效.
研究的目的:
- 为了评估imlifidase治疗的作用机制,效率和安全性.
- 为临床使用imlifidase在高风险移植接受者提供框架.
- 为了解决对imlifidase疗效进行比较研究和随机试验的需要.
主要方法:
- 对imlifidase的临床前和临床研究的审查.
- 对伊米利菲达酶的IgG降解机制和特异性的分析.
- 在免疫学上高风险的移植接受者中评估安全性和有效性数据.
主要成果:
- 伊姆利菲达斯在阳性交叉匹配移植接受者的IgG降解方面表现出快速和高的有效性.
- 在IgG反弹后的imlifidase施用需要在移植后的早期免疫抑制.
- 目前的数据缺乏对传统脱敏方案的比较研究.
结论:
- 伊姆利菲达斯是移植接受者具有积极交叉匹配的有前途的治疗选择.
- 有效的管理需要了解IgG反弹,并实施强大的免疫抑制策略.
- 进一步的大规模,随机对照试验是建立imlifidase的比较疗效和安全性至关重要的.
更多相关视频
07:13Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.3K
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
1.6K
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:22Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...